Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
- 1 December 2009
- journal article
- review article
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 15 (10), 728-741
- https://doi.org/10.1016/j.parkreldis.2009.09.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseMovement Disorders, 2009
- Long-term experience with continuous duodenal levodopa–carbidopa infusion (Duodopa): report of six patientsNeurological Sciences, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson DiseaseClinical Neuropharmacology, 2008
- Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s DiseaseNeurodegenerative Diseases, 2008
- Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcomeMovement Disorders, 2007
- Does ageing influence deep brain stimulation outcomes in Parkinson's disease?Movement Disorders, 2007
- Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?Neurology, 2007
- Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomesJournal of Neurosurgery, 2005
- Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challengesMovement Disorders, 2004